![PDF) Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? PDF) Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?](https://i1.rgstatic.net/publication/340468171_Gepants_calcitonin-gene-related_peptide_receptor_antagonists_what_could_be_their_role_in_migraine_treatment/links/5ea00ed8a6fdccda592c35ac/largepreview.png)
PDF) Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
![PDF) Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study PDF) Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study](https://i1.rgstatic.net/publication/351085138_Effects_of_fremanezumab_in_patients_with_chronic_migraine_and_comorbid_depression_Subgroup_analysis_of_the_randomized_HALO_CM_study/links/609be3e1a6fdccc3ce6eb264/largepreview.png)
PDF) Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
![PDF) Randomized, controlled trial of telcagepant for the acute treatment of migraine | Tony W Ho - Academia.edu PDF) Randomized, controlled trial of telcagepant for the acute treatment of migraine | Tony W Ho - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/87645569/mini_magick20220617-10493-1go2nnc.png?1655463012)
PDF) Randomized, controlled trial of telcagepant for the acute treatment of migraine | Tony W Ho - Academia.edu
![PDF) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life PDF) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life](https://i1.rgstatic.net/publication/7386487_Clinical_trials_of_acute_treatments_for_migraine_including_multiple_attack_studies_of_pain_disability_and_health-related_quality_of_life/links/59dcebf70f7e9b2120321e06/largepreview.png)
PDF) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life
![PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine](https://i1.rgstatic.net/publication/303832194_A_phase_IIb_randomized_double-blind_placebo-controlled_trial_of_ubrogepant_for_the_acute_treatment_of_migraine/links/59dceb5d0f7e9b2120321d69/largepreview.png)
PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
![PDF) Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized PDF) Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized](https://www.researchgate.net/publication/360184916/figure/fig1/AS:1148929597026305@1650937570902/Participant-flow-diagram-LTF-lost-to-follow-up-ITT-intent-to-treat-mITT-modified_Q320.jpg)
PDF) Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized
![PDF) Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review PDF) Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review](https://i1.rgstatic.net/publication/8608042_Double-Blind_Clinical_Trials_of_Oral_Triptans_Vs_Other_Classes_of_Acute_Migraine_Medication_-_A_Review/links/5ea73b0ba6fdccd79459d09a/largepreview.png)
PDF) Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review
![PDF) Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches: Headache PDF) Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches: Headache](https://i1.rgstatic.net/publication/330745597_Efficacy_of_ADAM_Zolmitriptan_for_the_Acute_Treatment_of_Difficult-to-Treat_Migraine_Headaches_Headache/links/5c5256ad299bf12be3efe3ee/largepreview.png)
PDF) Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches: Headache
![PDF) Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks PDF) Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks](https://i1.rgstatic.net/publication/242186858_Evidence-Based_Guidelines_for_Migraine_Headache_in_the_Primary_Care_Setting_Pharmacological_Management_of_Acute_Attacks/links/0a85e530596fec39b4000000/largepreview.png)
PDF) Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks
![PDF) Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES ( PDF) Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES (](https://www.researchgate.net/profile/Francesco-Nonino/publication/366158586/figure/tbl5/AS:11431281106353853@1670629325301/European-retail-price-of-triptans-paracetamol-and-aspirin_Q320.jpg)
PDF) Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES (
![PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine](https://www.researchgate.net/profile/Richard-Lipton/publication/303832194/figure/fig3/AS:669336586956806@1536593686321/Proportion-of-migraine-participants-meeting-the-pain-freedom-endpoint-through-eight-hours_Q320.jpg)
PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
![PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry](https://www.researchgate.net/publication/374585839/figure/fig4/AS:11431281206263544@1700621963246/Frequency-of-response-and-reasons-for-failure-of-specific-triptans-A-Triptan-responders_Q320.jpg)
PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry
![PDF) Raynaud's Phenomenon Associated With Calcitonin Gene‐Related Peptide Monoclonal Antibody Antagonists PDF) Raynaud's Phenomenon Associated With Calcitonin Gene‐Related Peptide Monoclonal Antibody Antagonists](https://i1.rgstatic.net/publication/334499568_Raynaud's_Phenomenon_Associated_With_Calcitonin_Gene-Related_Peptide_Monoclonal_Antibody_Antagonists/links/60197dd4458515893978b818/largepreview.png)